Drugging cancer genomes
Nat Rev Drug Discov
.
2013 Dec;12(12):889-90.
doi: 10.1038/nrd4184.
Authors
Paul Workman
1
,
Bissan Al-Lazikani
Affiliation
1
Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, UK.
PMID:
24287764
DOI:
10.1038/nrd4184
No abstract available
MeSH terms
Animals
Antineoplastic Agents / administration & dosage*
Drug Delivery Systems / trends
Gene Targeting / trends
Genome, Human / genetics*
Humans
Neoplasms / drug therapy
Neoplasms / genetics*
Substances
Antineoplastic Agents
Grants and funding
11566/CRUK_/Cancer Research UK/United Kingdom